IsoRay Inc (ISR) Stock
ISR is no longer traded. IsoRay was delisted from the NYSE American in April 2023.
Prices on this page are historical; the last trade was April 21, 2023 at $0.69.
IsoRay stock price history
ISR final trading statistics
- Final close
- $0.69
- Final trading day
- Apr 21, 2023
- Market cap at delisting
- $192.19M
- Shares outstanding
- 278.66M
- Final 52-week range
- $0.19 – $0.70
- Avg. volume (final 3 mo.)
- 634,987
- All-time high (split-adj.)
- $2625.00 · Feb 1988
- All-time low (split-adj.)
- $0.03 · Apr 2004
- Return since IPO
- -97.5%
- Beta
- 1.49
- Book value / share
- $0.39
- Price / book
- 1.78
IsoRay annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $10.79M | -$7.2M | -$0.05 |
| FY2021 | $10.05M | -$3.2M | -$0.04 |
| FY2020 | $9.68M | -$3.3M | -$0.05 |
| FY2019 | $7.31M | -$4.8M | -$0.08 |
| FY2018 | $5.92M | -$6.7M | -$0.12 |
Last five fiscal years reported before the delisting; fiscal year ending June. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About IsoRay Inc
Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
IsoRay stock FAQ
What happened to IsoRay stock?
IsoRay stock was delisted from the NYSE American. Its final close was $0.69 on April 21, 2023.
Is ISR stock still trading?
No. ISR was delisted from the NYSE American in April 2023 and no longer trades on a U.S. exchange.
What was the last price of ISR stock?
ISR closed at $0.69 on its final trading day, April 21, 2023, for a market value of about $192.19M.
What were IsoRay's revenue and earnings in its last full fiscal year?
IsoRay reported revenue of $10.79M and net income of -$7.2M in fiscal 2022, its last full year as a public company.
When did IsoRay go public?
IsoRay Inc stock began trading on November 10, 2005.